BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36122619)

  • 1. Chemical-induced degradation of PreS2 mutant surface antigen via the induction of microautophagy.
    Yang JY; Wu YH; Pan MY; Chiou YT; Lee RK; Li TN; Wang LH
    Antiviral Res; 2022 Nov; 207():105417. PubMed ID: 36122619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic hepatitis B virus large surface antigen induces hepatocyte hyperploidy via failure of cytokinesis.
    Li TN; Wu YJ; Tsai HW; Sun CP; Wu YH; Wu HL; Pei YN; Lu KY; Yen TT; Chang CW; Chan HL; Tao MH; Liou JY; Chang MD; Su IJ; Wang LH
    J Pathol; 2018 Aug; 245(4):502-513. PubMed ID: 29862509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus PreS2-mutant large surface antigen activates store-operated calcium entry and promotes chromosome instability.
    Yen TT; Yang A; Chiu WT; Li TN; Wang LH; Wu YH; Wang HC; Chen L; Wang WC; Huang W; Chang CW; Chang MD; Shen MR; Su IJ; Wang LH
    Oncotarget; 2016 Apr; 7(17):23346-60. PubMed ID: 26992221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
    Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W
    J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus large surface protein is priming for hepatocellular carcinoma development via induction of cytokinesis failure.
    Musa J; Li J; Grünewald TG
    J Pathol; 2019 Jan; 247(1):6-8. PubMed ID: 30246253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis.
    Wang HC; Huang W; Lai MD; Su IJ
    Cancer Sci; 2006 Aug; 97(8):683-8. PubMed ID: 16863502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc-dependent interaction between JAB1 and pre-S2 mutant large surface antigen of hepatitis B virus and its implications for viral hepatocarcinogenesis.
    Hsu JL; Chuang WJ; Su IJ; Gui WJ; Chang YY; Lee YP; Ai YL; Chuang DT; Huang W
    J Virol; 2013 Dec; 87(23):12675-84. PubMed ID: 24049181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.
    Hsieh YH; Su IJ; Yen CJ; Tsai TF; Tsai HW; Tsai HN; Huang YJ; Chen YY; Ai YL; Kao LY; Hsieh WC; Wu HC; Huang W
    Carcinogenesis; 2013 Feb; 34(2):475-85. PubMed ID: 23172669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N-linked glycosylation modifications in the hepatitis B surface protein impact cellular autophagy, HBV replication, and HBV secretion.
    Tepjanta P; Fujiyama K; Misaki R; Kimkong I
    PLoS One; 2024; 19(3):e0299403. PubMed ID: 38489292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of Hepatitis B virus sub-genotypes and incidence of preS1/preS2 region mutations in HBV-infected Egyptian patients from Mansoura.
    El-Mowafy M; Elgaml A; El-Mesery M; Elegezy M
    J Med Virol; 2017 Sep; 89(9):1559-1566. PubMed ID: 28390175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus PreS2 mutants in liver cancer patients.
    Li H
    Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(9):146-149. PubMed ID: 36905260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1.
    Hsieh YH; Su IJ; Wang HC; Tsai JH; Huang YJ; Chang WW; Lai MD; Lei HY; Huang W
    Mol Cancer Res; 2007 Oct; 5(10):1063-72. PubMed ID: 17951406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturally Occurring Hepatitis B Virus Mutations Leading to Endoplasmic Reticulum Stress and Their Contribution to the Progression of Hepatocellular Carcinoma.
    Choi YM; Lee SY; Kim BJ
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerobic glycolysis supports hepatitis B virus protein synthesis through interaction between viral surface antigen and pyruvate kinase isoform M2.
    Wu YH; Yang Y; Chen CH; Hsiao CJ; Li TN; Liao KJ; Watashi K; Chen BS; Wang LH
    PLoS Pathog; 2021 Mar; 17(3):e1008866. PubMed ID: 33720996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus large surface antigen promotes liver carcinogenesis by activating the Src/PI3K/Akt pathway.
    Liu H; Xu J; Zhou L; Yun X; Chen L; Wang S; Sun L; Wen Y; Gu J
    Cancer Res; 2011 Dec; 71(24):7547-57. PubMed ID: 21994334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes.
    Wang HC; Chang WT; Chang WW; Wu HC; Huang W; Lei HY; Lai MD; Fausto N; Su IJ
    Hepatology; 2005 Apr; 41(4):761-70. PubMed ID: 15726643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases.
    Raimondo G; Costantino L; Caccamo G; Pollicino T; Squadrito G; Cacciola I; Brancatelli S
    J Hepatol; 2004 Mar; 40(3):515-9. PubMed ID: 15123368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of LHBs with C53 promotes hepatocyte mitotic entry: A novel mechanism for HBV-induced hepatocellular carcinoma.
    Lei Y; Liu H; Yang Y; Wang X; Ren N; Li B; Liu S; Cheng J; Fu X; Zhang J
    Oncol Rep; 2012 Jan; 27(1):151-9. PubMed ID: 21971960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hepatitis B virus large surface protein (LHBs) is a transcriptional activator.
    Hildt E; Saher G; Bruss V; Hofschneider PH
    Virology; 1996 Nov; 225(1):235-9. PubMed ID: 8918553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9-mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV-positive hepatocellular carcinoma cells.
    Song J; Zhang X; Ge Q; Yuan C; Chu L; Liang HF; Liao Z; Liu Q; Zhang Z; Zhang B
    J Cell Biochem; 2018 Nov; 119(10):8419-8431. PubMed ID: 29904948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.